tiprankstipranks
Trending News
More News >
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Financial Statements

Compare
621 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently $100.21M. The company's EPS TTM is $-0.4; its P/E ratio is -14.16; Tenax Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -114.75K
Operating Income$ -19.49M$ -8.23M$ -11.05M$ -32.73M$ -9.87M
EBITDA$ -17.58M$ -7.68M$ -10.93M$ -32.36M$ -9.74M
Net Income$ -17.60M$ -7.71M$ -11.05M$ -32.47M$ -9.85M
Balance Sheet
Cash & Short-Term Investments$ 94.85M$ 9.79M$ 2.12M$ 5.58M$ 6.71M
Total Assets$ 96.69M$ 11.68M$ 3.40M$ 5.99M$ 6.87M
Total Debt$ 0.00$ 500.90K$ 807.89K$ 290.78K$ 305.04K
Net Debt$ -94.85M$ -9.29M$ -1.32M$ -5.29M$ -5.95M
Total Liabilities$ 4.69M$ 3.59M$ 1.91M$ 1.75M$ 2.24M
Stockholders' Equity$ 91.99M$ 8.10M$ 1.49M$ 4.24M$ 4.63M
Cash Flow
Free Cash Flow$ -14.81M$ -5.90M$ -12.02M$ -10.86M$ -9.28M
Operating Cash Flow$ -14.81M$ -5.90M$ -12.01M$ -10.86M$ -9.27M
Investing Cash Flow$ 0.00$ 3.00K$ -2.32K$ 452.61K$ 20.11K
Financing Cash Flow$ 99.87M$ 13.57M$ 8.55M$ 9.74M$ 10.60M
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Tenax Therapeutics Debt to Assets

Tenax Therapeutics Cash Flow

Tenax Therapeutics Forecast EPS vs Actual EPS